PREVENTION OF ALLOGENEIC BONE-MARROW GRAFT-REJECTION BY H-2 TRANSGENE IN DONOR MICE

被引：198
|
作者：
OHLEN, C
KLING, G
HOGLUND, P
HANSSON, M
SCANGOS, G
BIEBERICH, C
JAY, G
KARRE, K
机构：
[1] KAROLINSKA INST,DEPT TUMOR BIOL,BOX 60400,S-10401 STOCKHOLM 60,SWEDEN
[2] MOLEC THERAPEUT INC,W HAVEN,CT 06516
[3] AMER RED CROSS,JEROME H HOLLAND LAB,VIROL LAB,ROCKVILLE,MD 20855
[4] KAROLINSKA INST,DEPT IMMUNOL,S-10401 STOCKHOLM 60,SWEDEN
[5] YALE UNIV,DEPT BIOL,NEW HAVEN,CT 06510
来源：
SCIENCE | 1989年 / 246卷 / 4930期
关键词：
D O I：
10.1126/science.2814488
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：666 / 668
页数：3
相关论文
共 50 条
  • [21] ULTRAVIOLET-IRRADIATION FOR THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE AND GRAFT-REJECTION IN BONE-MARROW TRANSPLANTATION
    HUDSON, JG
    LAWLER, M
    PAMPHILON, DH
    BONE MARROW TRANSPLANTATION, 1994, 14 (04) : 511 - 516
  • [22] PREVENTION OF GRAFT-REJECTION IN T-CELL DEPLETED BONE-MARROW TRANSPLANTATION USING UNRELATED DONORS
    CORNETTA, K
    BAUTE, J
    BROUN, ER
    CUNNINGHAM, I
    HEDDERMAN, A
    HROMAS, R
    KNEEBONE, P
    RUBIN, L
    SROUR, EF
    TRICOT, G
    BLOOD, 1993, 82 (10) : A79 - A79
  • [23] MARROW MAST-CELL COUNTS DO NOT PREDICT BONE-MARROW GRAFT-REJECTION
    SALE, GE
    MARMONT, P
    HUMAN PATHOLOGY, 1981, 12 (07) : 605 - 608
  • [24] DONOR CD8 CELLS PREVENT ALLOGENEIC MARROW GRAFT-REJECTION IN MICE - POTENTIAL IMPLICATIONS FOR MARROW TRANSPLANTATION IN HUMANS
    MARTIN, PJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02): : 703 - 712
  • [25] ROLE OF THE BONE-MARROW IN LYMPHOMA GRAFT-REJECTION IN MHC TRANSGENIC C57BL MICE
    HOGLUND, P
    BIEBERICH, C
    GLAS, R
    YOSHIOKA, T
    JAY, G
    KARRE, K
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (04) : 398 - 398
  • [26] GRAFT-REJECTION AFTER TRANSPLANTATION OF T-CELL-DEPLETED BONE-MARROW
    HERTENSTEIN, B
    ARNOLD, R
    BUNJES, D
    SCHMEISER, T
    WIESNETH, M
    HEIMPEL, H
    HEIT, W
    BLUT, 1986, 53 (03): : 187 - 188
  • [27] GRAFT-REJECTION AND TOXICITY FOLLOWING BONE-MARROW TRANSPLANTATION IN RELATION TO BUSULFAN PHARMACOKINETICS
    SLATTERY, JT
    SANDERS, JE
    BUCKNER, CD
    SCHAFFER, RL
    LAMBERT, KW
    LANGER, FP
    ANASETTI, C
    BENSINGER, WI
    FISHER, LD
    APPELBAUM, FR
    HANSEN, JA
    BONE MARROW TRANSPLANTATION, 1995, 16 (01) : 31 - 42
  • [28] T-CELL DEPLETION AND SIZE OF ALLOGENEIC BONE-MARROW GRAFTS - ANALYSIS OF THEIR INFLUENCE ON GRAFT-REJECTION IN A MURINE SYSTEM
    GLASS, B
    UHAREK, L
    GASSMANN, W
    LOEFFLER, H
    MUELLERRUCHHOLTZ, W
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 582 - 582
  • [29] CYTOTOXIC LYMPHOCYTES-T MEDIATE GRAFT-REJECTION FOLLOWING BONE-MARROW TRANSPLANTATION
    BIERER, BE
    EMERSON, SG
    MAZIARZ, R
    SMITH, BR
    BURAKOFF, SJ
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 623 - 623
  • [30] REJECTION OF ALLOGENEIC BONE-MARROW CELLS
    VRIESENDORP, HM
    BLOOD, 1987, 70 (03) : 889 - 890
12345